Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Hypnovel 10mg/2ml Solution for Injection – PA2239/007/001
- Levofloxacin 500mg Tablet – PA1347/048/002
- Octreotide 100mcg/ml Solution for Injection – PA0822/218/002
- Pipercin 4g/0.5g Solution for Infusion – PA0126/180/002
- Vedixal XL 150mg Prolonged Release Capsule – PA1445/016/002
- Yaz 0.02mg/3mg Film Coated Tablet – PA1410/056/001
- Zyban 150mg Prolonged Release Tablet – PA1077/017/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Atenomel 50mg Tablet – PA0126/069/001
- Canesten 200mg Pessary – PA1410/039/008
- Canesten Duopak 100mg/1% w/w Pessary & Cream – PA1410/039/005
- Celecoxib 200mg Capsule – PA0711/241/002
- Creon 25000 Gastro-resistant Capsule – PA2010/008/002
- Diabrezide 80mg Tablet – PA0925/001/001
- Efexor XL 150mg Prolonged Release Capsule – PA0822/072/003
- Imdur 60mg Prolonged Release Tablet – PA2129/001/001
- Lyrica 75mg Capsule – EU/1/04/279/012
- Verap 240mg Prolonged Release Tablet – PA0711/016/005
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.